Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SRx Health Solutions (SRXH) Non Operating Investment Income (2017 - 2020)

Historic Non Operating Investment Income for SRx Health Solutions (SRXH) over the last 4 years, with Q4 2020 value amounting to $102000.0.

  • SRx Health Solutions' Non Operating Investment Income rose 21333.33% to $102000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$538000.0, marking a year-over-year decrease of 16758.79%. This contributed to the annual value of $2.2 million for FY2020, which is 256666.67% up from last year.
  • SRx Health Solutions' Non Operating Investment Income amounted to $102000.0 in Q4 2020, which was up 21333.33% from $4.2 million recorded in Q3 2020.
  • In the past 5 years, SRx Health Solutions' Non Operating Investment Income registered a high of $4.2 million during Q3 2020, and its lowest value of -$3.5 million during Q2 2020.
  • Moreover, its 4-year median value for Non Operating Investment Income was -$75998.0 (2017), whereas its average is -$49491.4.
  • The largest annual percentage gain for SRx Health Solutions' Non Operating Investment Income in the last 5 years was 29045.41% (2020), contrasted with its biggest fall of 170000.0% (2020).
  • SRx Health Solutions' Non Operating Investment Income (Quarter) stood at $111281.0 in 2017, then skyrocketed by 182.19% to $314021.0 in 2018, then plummeted by 128.66% to -$90000.0 in 2019, then surged by 213.33% to $102000.0 in 2020.
  • Its Non Operating Investment Income was $102000.0 in Q4 2020, compared to $4.2 million in Q3 2020 and -$3.5 million in Q2 2020.